Trading update

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to confirm that based on its current unaudited accounts at 20^th June, it is trading ahead of market expectations for its full financial year ending 30^th June 2018.

Click here to read in full